Assessment of exposure-response relationship for bevacizumab in patients with metastatic colorectal cancer.
Peña-Cabia S, Royuela Vicente A, Ramos Díaz R, Gutiérrez Nicolás F, Peñalver Vera Á, Siso García I, Hitt Sabag R, García Lacalle C, Peña-Cabia A, Iglesias-Peinado I, García Díaz B, López-Martín A.
Peña-Cabia S, et al. Among authors: ramos diaz r.
Biomed Pharmacother. 2021 Sep;141:111827. doi: 10.1016/j.biopha.2021.111827. Epub 2021 Jun 18.
Biomed Pharmacother. 2021.
PMID: 34153845
Free article.